Kivu Bioscience
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$92M
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates for cancer treatment.
Focus Areas
Biotech
Antibody-drug conjugates
Oncology
Clinical development
Drug stability
Cancer therapies
Investors
